Page 145 - Read Online

Novotny et al. Vessel Plus 2022;6:51 https://dx.doi.org/10.20517/2574-1209.2021.139 Page 15 of 15

25. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9. DOI
PubMed
26. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the framingham study. Stroke
1991;22:983-8. DOI PubMed
27. Taylor NE, O’ Brien S, Edwards FH, Peterson ED, Bridges CR. Relationship between race and mortality and morbidity after valve
replacement surgery. Circulation 2005;111:1305-12. DOI PubMed
28. Minha S, Barbash IM, Magalhaes MA, et al. Outcome comparison of African-American and caucasian patients with severe aortic
stenosis subjected to transcatheter aortic valve replacement: a single-center experience. Catheter Cardiovasc Interv 2015;85:640-7.
DOI PubMed
29. Alqahtani F, Aljohani S, Almustafa A, et al. Comparative outcomes of transcatheter aortic valve replacement in African American and
caucasian patients with severe aortic stenosis. Catheter Cardiovasc Interv 2018;91:932-7. DOI PubMed
30. Hernandez-Suarez DF, Ranka S, Villablanca P, et al. Racial/Ethnic disparities in patients undergoing transcatheter aortic valve
replacement: insights from the healthcare cost and utilization project’s national inpatient sample. Cardiovasc Revasc Med
2019;20:546-52. DOI PubMed PMC
31. Martin E, Dagenais F, Voisine P, et al. Surgical aortic valve replacement outcomes in the transcatheter era. J Thorac Cardiovasc Surg
2015;150:1582-8. DOI PubMed
32. Jiménez-García R, Perez-Farinos N, Miguel-Díez J, et al. National trends in utilization and in-hospital outcomes of surgical aortic
valve replacements in spain, 2001-2015. Braz J Cardiovasc Surg 2020;35:65-74. DOI PubMed PMC
33. Capodanno D, Barbanti M, Tamburino C, et al; OBSERVANT Research Group. A simple risk tool (the OBSERVANT score) for
prediction of 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2014;113:1851-8. DOI PubMed
34. Bianco V, Kilic A, Gleason TG, et al. Long-term hospital readmissions after surgical vs. transcatheter aortic valve replacement. Ann
Thorac Surg 2019;108:1146-52. DOI PubMed
35. Hirji SA, Cote C, Lee J, et al. Transcatheter vs. surgical aortic valve replacement in patients with interstitial lung disease. J Card Surg
2020;35:571-9. DOI PubMed
36. Kadri AN, Bernardo M, Assar SZ, Werns S, Abbas AE. Surgical versus transcatheter aortic valve replacement in patients with
malignancy. Cardiovasc Revasc Med 2021;23:59-65. DOI PubMed
37. Forcillo J, Condado JF, Binongo JN, et al. Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk
patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2017;154:445-52. DOI PubMed
38. Sanchez CE, Hermiller JB Jr, Pinto DS, et al. Predictors and risk calculator of early unplanned hospital readmission following
contemporary self-expanding transcatheter aortic valve replacement from the STS/ACC TVT registry. Cardiovasc Revasc Med
2020;21:263-70. DOI PubMed
39. Yerasi C, Tripathi B, Wang Y, et al. National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve
replacement: an analysis from the nationwide readmissions database, 2012-2016. Am Heart J 2021;231:25-31. DOI PubMed